News
After checking the over-the-counter drugs using a low-heat method of testing, the FDA said it found much lower levels of NDMA than was discovered with a higher temperature test employed by Valisure.
In addition to advising on contraception, the MHRA has issued an alert regarding the use of GLP-1 drugs for weight loss, raising concerns about their safety, particularly during pregnancy and ...
UK medicines watchdog the Medicines and Healthcare Products Regulatory Agency (MHRA) slapped an alert on one batch of Zaditen 0.25mg/ml eye drops, used to treat seasonal allergies such as hay fever.
The MHRA described the recall as Class 2, which means the defect may cause mistreatment or harm to the patient but is not life-threatening or serious. It applies to two batches of pills.
An analysis of global usage patterns of a common hypertension drug following a major recall demonstrates the worldwide impact of contamination at a single manufacturing facility. The research, led by ...
More than 7,700 packs that have already been distributed are subject to the recall, according to the MHRA. People with the wrongly-labelled medication are being urged to contact their GP or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results